February 15, 2017
Navamedic reports slight increase of EBITDA for Q4 2016
Navamedic, Norwegian medtech and pharmaceutical products company, has reported Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) of €0,6 million which represents small increase comparing to same period last year when company’s EBITDA was slightly under zero.